Although PD-L1 expression in multiple types of immune cells or tumor cells has been reported8,9, there is no consensus as to which immune cell fraction is responsible for the substantial function of the PD-L1 pathway in breast cancer. This evidence concerns the gene CD274 and breast carcinoma.